See you next week for Nick Petty’s ( @npetty.bsky.social ) defense! Title: Replacement of microglia with hematopoietic stem cell-derived microglia-like cells in nonhuman primates & impact of CSF1R inhibitor treatment Lab: Kiem Lab, FH When: Wed, Nov 5, 3:30pm PST Where: FH Pelton Auditorium & Zoom

Join us for Nick Petty’s (@npetty.bsky.social ) dissertation defense! Title: Replacement of microglia with hematopoietic stem cell-derived microglia-like cells in nonhuman primates & impact of CSF1R inhibitor treatment Lab: Kiem Lab, FH When: Wed, Nov 5, 3:30pm PST Where: FH Pelton Auditorium & Zoom

Spent the past few days visiting the @fredhutch.bsky.social to celebrate the impact of Dr. Rainer Storb on hematology & the thousands of patients living with blood disorders as the @ash.hematology.org Coulter Award winner. Dr. Storb’s passion, curiosity, and persistence is so inspiring. #ASH25

Nature reports how the Trump administration’s anti-mRNA sentiment has sparked fears that this once-celebrated technology, widely seen as a major engine of next-generation vaccines and therapeutics, could soon find itself on the chopping block. #medsky 🧪

Researchers in Dr. Hans-Peter Kiem's lab at Fred Hutch devised a method that could one day treat genetic hematologic disorders by correcting how the body makes blood cells. Read more about their work, which they presented recently at #ASGCT2025. www.fredhutch.org/en/news/cent...

NEW: The NIH has begun terminating grants for active projects studying gender identity, DEI, environmental justice, climate change, among other topics. At least 16 termination letters have already been sent — and hundreds more are coming, people inside NIH tell me. www.nature.com/articles/d41...

"… it is the words and actions of all members of the scientific community … that form the collective voice of science …," writes @holdenthorp.bsky.social in a new #ScienceEditorial. scim.ag/4hR6ux0

“There’s going to be a missing age class of researchers that will reverberate for years.” scim.ag/3ERRLDo

Happy to share a preprint for a forthcoming article in Blood Advances! I had the privilege to work with a super talented team here in Dr. Kiem's lab to contribute to the growing body of work showing safety and efficacy of CD33 CAR T cells for the treatment of AML.